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Addiction Care Program
Overview
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High-Level Overview of Program
In April of 2017, the Maine Health Access Foundation (MeHAF) provided funds to ten
grantee sites to expand access to patient-centered addiction care for people with
opioid use disorder (OUD) through their Addiction Care Program.

Grantee Strategies
Grantee programs
increase the
availability of
medication-assisted
treatment (MAT) in
primary care
settings.

Outcome
More people with
opioid use disorder
(OUD) are in
treatment and
recovery.

System Change
Maine has an
expanded
treatment
infrastructure for
OUDs.
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Addiction Care Program Grantees
There are 10 Addiction Care Program grantees located throughout Maine. Each
grantee is engaging in comprehensive planning and implementation activities
designed to build capacity to provide medication-assisted treatment (MAT) in
primary care settings.

Program Components: Technical Assistance
Qualidigm:
Training, education, and technical assistance to support grantee
organizations, both individually and as a cohort.
Haram Consulting, Eric Haram, LADC:
Technical assistance to sites around integrated treatment models for
OUDs.
Maine Behavioral Healthcare, Mary Jean Mork, LCSW:
Technical assistance related to billing / coding for MAT services.
Maine Medical Association:
Technical assistance related to public policy.

Program Components: Evaluation
The Addiction Care Program evaluation is being led by the Muskie
School. Evaluation data is collected from a variety of sources
including surveys, administrative data, continuous quality
improvement measures, interviews, and focus groups. This mixed
methods approach:
• informs current and future planning activities;
• guides the implementation and refinement of the intervention
strategies;
• provides ongoing feedback to grantee organizations on
improvements to access and delivery of MAT in their region;
and
• offers a summative assessment of the implementation
experience and documents grantee organization milestones
and successes.

Evaluation Methods
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Evaluation Framework
The program evaluation utilized traditional evaluation techniques in
tandem with quality improvement strategies to provide rapid cycle
feedback to help inform grantee planning and implementation activities.
Share Data
and Learn
Ongoing
Data Sharing & Learning
Technical
Assistance

Understand
Barriers and
Facilitators

Grantee
Programs

Qualidigm
& Haram
Consulting

Evaluation
USM
Muskie

Assess
Outcomes

Collect Data,
Make
Observations

Data Sources: Quantitative
Surveys
•

Health Systems, Practice, and
Provider Survey:

•

•

Interim Planning Site Survey:

•

•

Fall 2017: 150 respondents

Summer 2018: 27 respondents

Provider Survey:

•

Data Dashboards
•
•

Custom data collection dashboards
created for all 10 grantees
Dashboards were submitted quarterly
in both years and included the
following:

•
•
•
•

Continuous quality improvement
metrics
Site-specific metrics
Community engagement logs
Training/ education log

Spring 2019: 31 respondents
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Data Sources: Qualitative
Patient Focus Groups

Provider Interviews

•

•

•

•

Year One: questions around patient
perspectives on opioid use in the
state, personal experiences with
addiction and treatment, personal
experiences with M AT, engagement
in the Addiction Care Program, and
patient-centered care
Year Two: questions around
personal experiences seeking
treatment, experiences with M AT,
treatment engagement, recovery
coaches, and patient-centered care

•

•

Year One: provider experiences,
opinions on M AT, challenges,
strategies, and organizational
needs
Year Two: change team feedback
on barriers and facilitators to
collaboration, planning and
implementation, lessons learned,
and next steps
102 providers participated in
interviews at grantee
organizations

37 patients participated in focus
groups at grantee organizations
10

Patient Perspectives
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What did we hear from patients?
•

Patients cite a number of reasons for why initiating and engaging in treatment
can be difficult, even when they are ready to seek help. The majority indicated
that there is often no clear path for individuals seeking treatment for OUDs.

•

The majority of patients indicated that lack of insurance and the cost
associated with treatment are the greatest barriers to accessing and engaging
in MAT.
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What did we hear from patients? Key Program Components
Patients identified a number of factors that they feel are important components of a
successful MAT program. Creating treatment protocols and policies that include
interventions specific to the tasks and challenges faced by patients at each stage of
the treatment, maintenance and recovery; supportive staff and family; and
addressing social determinants were frequently cited as important elements of MAT.
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What did we hear from patients? Promoting Long-Term Recovery
Consistent and rapid access to MAT, auxiliary recovery supports (housing,
employment, transportation), social supports as well as opportunities for
community engagement were the most frequently mentioned factors
necessary to support ongoing maintenance and recovery.
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Capacity Building
Milestones
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Capacity Building: Community Engagement
Over the course of two years, grantees engaged with their community through
diverse mechanisms and focused on various topics.
Types of Community Engagement
Advisory Board Meeting

76

Roundtable or Group Discussion

76

Presentation or Educational Event

18

Article - Newspaper

13

TV Feature

12

Radio Feature

11

In-Person Training

Youth Engagement

4

22

Prevention

6
4

35

Reducing Stigma

9

Social Media Campaign

41

Treatment Options

25

Article - Online

65

General OUD/SUD Education

31

Grant Planning Team Meeting

102

Recovery Supports

52

Flyer Distribution

Other

Community Organizing

57

Public Meeting or Forum

Press Release or Conference

Topics of Community Engagement

113

15

Prescription Drug Use

8

Chronic Pain Management

3

Social Determinants of Health

2

Other

208

Note: The “other” category is comprised of site-specific types and topics of community engagement that were not rolled into a specific category.
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Capacity Building: Training and Education
Over the course of two years, grantees held a variety of training and education
opportunities. They utilized diverse mechanisms and focused on various topics.

6,322 Attendees Recorded*

585 Training/Education Sessions Recorded

*This is not individual attendees (i.e. attendees may be at more than one
session and counted multiple times)

Primary Training Topics
Prescription Drug Use
Social Determinants of Health
Billing, Coding, and Reimbursement
Safe and Compassionate Tapering
Data Sharing / Universal Release
Naloxone Training
Maternity Care and/or Snuggle ME Guidelines
Safe Prescribing & Prescribing Limits
Patient Engagement Strategies
Technology
MAT Policies
Prescribing Guidelines and Laws
Role Specific Training
Chronic Pain Management
Reducing Stigma
Community Organizing
X Waiver Training
Workflow Implementation
Peer Sharing
Prevention
Diagnosing and Treating Addiction
Grant Related
Hub and Spoke Model
Recovery / Peer Recovery
Addiction/ OUDs / Opioids
Other

1
2
3
4
4

6
6
7
8
9
10
11

Training/Education Duration
Less than 1 hour

57

1-2 hours
18
19

23
23

27
29
30
32

3-5 hours

46

6-8 hours

53

2 Days
43

51
52
54
55

394

More than 2 days

9
11

58
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Capacity Building: Providers
The number of waivered providers is increasing
Since the inception of the program the number of providers delivering MAT
increased five times — from 27 providers to 136

Total Number of Providers Delivering MAT

98

48
27

52

49

61

73

73

60

66

106 107 110
100 101 101 103 102

130
124 127

136

66

27

“I feel some of our greatest success has been the continuous addition of providers to
our team” (Provider, Year Two)
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Capacity Building: Providers
By the end of Year Two, providers were also more
confident in their organization’s ability to integrate M AT
into their clinical work and more convinced that it is
important to do so.
By Year Two, providers:
• Felt more knowledgeable about their work related to OUD
• Had increased satisfaction with the way they work with individuals with OUD
• Felt they had increased support from colleagues
• Were more motivated to work with individuals with OUD
“There’s always more to learn but as I have continued to work with
people I have certainly gained confidence that I am providing
competent and quality care to meet patients’ needs.”
- (Provider, Year Two)
19

Programmatic Milestones
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Capacity Building: Patient Panels
More patients are receiving MAT
As of March 2019, grantees served nearly 11 times the patients as they did in
October of 2018.

Number of Patients on MAT by Month
1200

969 *

1000
800
600
400
200

89

0

*Note: more grantees reported on this metric in 2019.
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Capacity Building: Screening
More patients have OUD documented in their records
The number of patients with documented OUD was 1.4 times higher in March of
2019 compared to the previous year.

Number of Patients with Documented OUD
1400

1,151

1200
1000

822

800
600
400
200
0
Apr-18

May-18

Jun-18

Jul-18

Aug-18

Sep-18

Oct-18

Nov-18

Dec-18

Jan-19

Feb-19

Mar-19
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Capacity Building: Wait Times
Average wait times decreased over time
Despite wait times varying across grantees, the average wait time from MAT
referral to induction appointment decreased from nearly a month, to 5 days.
Average Wait Time (days)
35
30

29

25
20
15
10

5

5
0

Nov-17

Dec-17

Jan-18

Feb-18

Mar-18

Apr-18

May-18

Jun-18

Jul-18

Aug-18

Sep-18

Oct-18

Nov-18

Dec-18

Jan-19

Feb-19

Mar-19
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Lessons Learned
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Lessons Learned: What Factors Facilitated Success?
Treatment Approaches
•
•
•

Flexible Policies
Patient-centered
Variety of Tx Options

Community Partnerships

•
•
•

Needed Resources

•
•
•

Staff
Infrastructure
Education

Early Engagement
Cross-sector
Collaboration
Establish Referral
Pathways

Other Factors to Consider:
Learning from Others

Culture Shift and Change
Politics
•
•
•
•

Philosophical Alignment
Importance of M AT
Peer Support
Provider Buy-In

Time Burdens
25

Lessons Learned: What Factors Facilitated Success?
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Lessons Learned: Providing Patient-Centered Care
MeHAF Addiction Care Program Year Two:
Grantee Responses to Patient Feedback
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Summary of Key Findings
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Key Findings from Grantee Sites
•
Engagement

Infrastructure

Flexibility

Other

•

Recruit providers to participate (and be aware of barriers to recruitment)
Engage partners early

•

Convene a diverse advisory group

•

Understand the types of providers and support staff that will be needed
for the program

•

Establish a relationship with a pharmacy/pharmacist

•

Plan out the program’s infrastructure (e.g. processes for registrations,
schedule, finances)

•

Have a project coordinator or designate someone who will push the work
forward (strong leadership)

•

Individualization for patients

•

Flexibility for the program as it grows

•

Don’t make assumptions (e.g. about who will want to participate and who
won’t, who is educated around issues related to substance use disorders)

•

Find time to educate yourself about relevant topics (e.g. OUDs, substance
use disorders, needle exchanges, etc.)

•

Be aware of your environment (e.g. politics)

•

Prepare for lots of hard work, but it will pay off with rewarding
experiences
29

Key Findings
•

Payment / Reimbursement for Services: Our findings indicate that the costs
associated with MAT remains the primary barrier for individuals with OUD to
accessing treatment and maintaining recovery. Access to insurance coverage
and affordable treatment options are critical components to initiating and
engaging patients in MAT.

•

Low Barrier Access to Treatment: Given the chronic nature of OUDs, creating low
barrier access to MAT is a critical component to ensuring treatment initiation and
ongoing engagement.

•

Patient-Centered Approach: There is a need for organizations to focus on
creating treatment protocols and policies that include interventions specific to
the tasks and challenges faced by patients at each stage of the treatment,
maintenance and recovery.

•

Auxiliary Recovery Supports: Access to wrap-around services (i.e. addressing
social determinants of health), are crucial elements of patient care that promote
long-term maintenance and recovery for individuals with OUDs.

•

Information for Patients and Families: Finding and accessing treatment for OUDs is
difficult for patients and they often did not know what services were available in
their community. Clearer communication about available resources is an
important element to facilitating treatment engagement.
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Key Findings
•

Capacity Building: Education and training opportunities as well as engaging in
a thorough program planning process are critical to building primary care
practices’ capacity to deliver MAT.

•

Stakeholder Engagement: Creating sustainable, effective linkages between
clinical and community settings can improve patients' access to treatment and
recovery supports by fostering partnerships between clinical providers,
community organizations, and public health agencies.

•

Organizational and Peer Support: Organizational resources and supports for
providers can facilitate the expansion of MAT in primary care settings.
Professional mentoring, particularly among new MAT providers is also essential
for supporting the expansion efforts.

•

Stigma: The stigma associated with opioid use remains a major barrier for
providers of MAT as well as patients in treatment and recovery. There remains a
need to address stigma surrounding opioids and to educate the community
about OUDs and MAT.

31

Future Directions
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Next Steps
In the upcoming year, grantee organizations will continue to work on addressing
the needs identified by patients in an effort to promote treatment engagement
and long-term recovery.

Stigma

Primary Care
Resistance &
Capacity

Financial
Models

Harm
Reduction
Support

Auxiliary Support
Connections

Accessibility
for Most-AtRisk Patients

Availability of Real-Time
Information about
Community Supports
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“

“My dream is someday that the
opiate use disorder will be actually
the same as COPD, diabetes,
hypertension. I think it will come.”
Provider, Year One
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Questions?
Lindsey Smith, PhD, MSW
m.lindsey.smith@maine.edu
Rachel Gallo, MPH
Rachel.gallo@maine.edu
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